<p><strong>Healius Limited</strong> (ASX:HLS) 的股東應該對過去一個月股價上漲 23% 感到高興。但不要羨慕持有者——回顧過去五年，回報實在糟糕。在此期間，股價下跌了 73%，讓人失望。因此，我們對短期的上漲持謹慎態度。然而，在最好的情況下（遠非 <em>既成事實</em>），這種改善的表現可能會持續。</p>
<p>更令人鼓舞的是，公司在過去 7 天內增加了 8700 萬澳元的市值，因此讓我們看看能否找出導致股東在過去五年中虧損的原因。</p>
<p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。請查看完整名單，免費獲取。</p>
<p>由於 Healius 在過去 12 個月中出現虧損，我們認為市場可能更關注收入和收入增長，至少目前是這樣。一般來説，沒有利潤的公司預計每年都要增長收入，並且增長速度要快。可以想象，快速的收入增長在維持時，通常會導致快速的利潤增長。</p>
<p>在過去五年中，Healius 的收入每年縮減 3.9%。這並不是投資者通常想看到的。如果一家公司虧損，你希望它能夠增長，因此股價在此期間每年下跌 12% 也就不足為奇。購買一家虧損且不增長收入的公司的股票需要一定的心理韌性（或魯莽）。這並不是我們所知的成功投資者所追求的目標。</p>
<p>您可以在下面看到收益和收入隨時間的變化（點擊圖片可以發現確切的數值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908"/></p>
<p>ASX:HLS 收益和收入增長 2025 年 11 月 26 日</p>
<p>值得注意的是，我們在過去一個季度看到顯著的內部人士買入，這被我們視為積極信號。另一方面，我們認為收入和收益趨勢是衡量業務更有意義的指標。因此，查看分析師對 Healius 未來收益的看法（免費的利潤預測）是非常有意義的。</p>
<h2>總股東回報（TSR）如何？</h2>
<p>我們不能不提 Healius 的 <em>總股東回報</em>（TSR）與其 <em>股價回報</em> 之間的差異。TSR 是一種回報計算，考慮了現金股息的價值（假設收到的任何股息都被再投資）以及任何折扣融資和分拆的計算價值。由於其股息支付的歷史，Healius 的 TSR 在過去五年中下降了 57%，但並沒有股價回報那麼糟糕。</p>
<h2>不同的視角</h2>
<p>雖然整體市場在過去一年中上漲了約 5.8%，但 Healius 的股東卻損失了 2.7%。然而，請記住，即使是最好的股票，有時在十二個月內也會表現不佳。不幸的是，長期股東的損失更為嚴重，過去五年中損失了 9%。在認為股價會穩定之前，我們希望有明確的信息表明公司將會增長。內部人士買入股票固然好，但我們建議您查看內部人士的買入價格。</p>
<p>還有很多其他公司也有內部人士買入股票。您可能不想錯過這份 <strong>免費的</strong> 被低估的小型公司的名單，內部人士正在買入。</p>
<p><em>請注意，本文中引用的市場回報反映了當前在澳大利亞交易所交易的股票的市場加權平均回報。</em></p>

<p>Healius Limited（ASX:HLS）股票在過去一週上漲了 14%，在過去一個月上漲了 23%，但在五年內下跌了 73%。儘管公司在最近增加了 8700 萬澳元的市值，但五年來年收入縮減了 3.9%。有內部人士買入的情況被注意到，但長期股東面臨 57% 的總回報率下降。市場去年上漲了 5.8%，而 Healius 的股東則損失了 2.7%</p>

<p><strong>Healius Limited</strong> (ASX:HLS) shareholders should be happy to see the share price up 23% in the last month. But don't envy holders -- looking back over 5 years the returns have been really bad. The share price has failed to impress anyone , down a sizable 73% during that time. So we're hesitant to put much weight behind the short term increase. However, in the best case scenario (far from <em>fait accompli</em>), this improved performance might be sustained.</p>
<div class="lb-trans"><p><strong>Healius Limited</strong> (ASX:HLS) 的股東應該對過去一個月股價上漲 23% 感到高興。但不要羨慕持有者——回顧過去五年，回報實在糟糕。在此期間，股價下跌了 73%，讓人失望。因此，我們對短期的上漲持謹慎態度。然而，在最好的情況下（遠非 <em>既成事實</em>），這種改善的表現可能會持續。</p>
</div><p>On a more encouraging note the company has added AU$87m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.</p>
<div class="lb-trans"><p>更令人鼓舞的是，公司在過去 7 天內增加了 8700 萬澳元的市值，因此讓我們看看能否找出導致股東在過去五年中虧損的原因。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。請查看完整名單，免費獲取。</p>
</div><p>Because Healius made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.</p>
<div class="lb-trans"><p>由於 Healius 在過去 12 個月中出現虧損，我們認為市場可能更關注收入和收入增長，至少目前是這樣。一般來説，沒有利潤的公司預計每年都要增長收入，並且增長速度要快。可以想象，快速的收入增長在維持時，通常會導致快速的利潤增長。</p>
</div><p>In the last five years Healius saw its revenue shrink by 3.9% per year. That's not what investors generally want to see. If a business loses money, you want it to grow, so no surprises that the share price has dropped 12% each year in that time. It takes a certain kind of mental fortitude (or recklessness) to buy shares in a company that loses money and doesn't grow revenue. That is not really what the successful investors we know aim for.</p>
<div class="lb-trans"><p>在過去五年中，Healius 的收入每年縮減 3.9%。這並不是投資者通常想看到的。如果一家公司虧損，你希望它能夠增長，因此股價在此期間每年下跌 12% 也就不足為奇。購買一家虧損且不增長收入的公司的股票需要一定的心理韌性（或魯莽）。這並不是我們所知的成功投資者所追求的目標。</p>
</div><p>You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).</p>
<div class="lb-trans"><p>您可以在下面看到收益和收入隨時間的變化（點擊圖片可以發現確切的數值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908" alt="" original-src="https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908"/></p>
<p>ASX:HLS Earnings and Revenue Growth November 26th 2025</p>
<div class="lb-trans"><p>ASX:HLS 收益和收入增長 2025 年 11 月 26 日</p>
</div><p>It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. So it makes a lot of sense to check out what analysts think Healius will earn in the future (free profit forecasts).</p>
<div class="lb-trans"><p>值得注意的是，我們在過去一個季度看到顯著的內部人士買入，這被我們視為積極信號。另一方面，我們認為收入和收益趨勢是衡量業務更有意義的指標。因此，查看分析師對 Healius 未來收益的看法（免費的利潤預測）是非常有意義的。</p>
</div><h2>What About The Total Shareholder Return (TSR)?</h2>
<div class="lb-trans"><h2>總股東回報（TSR）如何？</h2>
</div><p>We'd be remiss not to mention the difference between Healius' <em>total shareholder return</em> (TSR) and its <em>share price return</em>. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Its history of dividend payouts mean that Healius' TSR, which was a 57% <em>drop</em> over the last 5 years, was not as bad as the share price return.</p>
<div class="lb-trans"><p>我們不能不提 Healius 的 <em>總股東回報</em>（TSR）與其 <em>股價回報</em> 之間的差異。TSR 是一種回報計算，考慮了現金股息的價值（假設收到的任何股息都被再投資）以及任何折扣融資和分拆的計算價值。由於其股息支付的歷史，Healius 的 TSR 在過去五年中下降了 57%，但並沒有股價回報那麼糟糕。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的視角</h2>
</div><p>While the broader market gained around 5.8% in the last year, Healius shareholders lost 2.7%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, longer term shareholders are suffering worse, given the loss of 9% doled out over the last five years. We would want clear information suggesting the company will grow, before taking the view that the share price will stabilize. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.</p>
<div class="lb-trans"><p>雖然整體市場在過去一年中上漲了約 5.8%，但 Healius 的股東卻損失了 2.7%。然而，請記住，即使是最好的股票，有時在十二個月內也會表現不佳。不幸的是，長期股東的損失更為嚴重，過去五年中損失了 9%。在認為股價會穩定之前，我們希望有明確的信息表明公司將會增長。內部人士買入股票固然好，但我們建議您查看內部人士的買入價格。</p>
</div><p>There are plenty of other companies that have insiders buying up shares. You probably do <strong>not</strong> want to miss this <strong>free</strong> list of undervalued small cap companies that insiders are buying.</p>
<div class="lb-trans"><p>還有很多其他公司也有內部人士買入股票。您可能不想錯過這份 <strong>免費的</strong> 被低估的小型公司的名單，內部人士正在買入。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.</em></p>
<div class="lb-trans"><p><em>請注意，本文中引用的市場回報反映了當前在澳大利亞交易所交易的股票的市場加權平均回報。</em></p>
</div>

Healius（ASX:HLS）的股東在過去一週內股價上漲了 14%，但在過去五年中仍然虧損